Search 

As the independent life science network for Wales, MediWales brings together industry, academia and the clinical community to support the advancement of human life science in Wales and create collaborations and business opportunities for our members

A bright future for patients with rare kidney disease Mironid® is developing novel small-molecule therapeutics that directly target the central signalling mechanism that drives ADPKD.